Strengthening our life sciences and regulatory capability with key hire in Paris

Specializing in pharmaceutical and regulatory law, Anne strengthens the global law firm’s offering with a dedicated practice focused on legal issues affecting the healthcare, pharmaceutical and biotechnology sectors.

Anne Servoir has more than 25 years’ experience advising leading pharmaceutical companies and start-ups in the pharmaceutical, biotech and medtech industries, both in France and internationally. She notably advises clients on their market access strategies, including early access to market, transition to standard reimbursement frameworks and pricing negotiations, as well as representing them in pre-litigation and litigation proceedings against decisions of regulatory authorities (including the ANSM and the CEPS).

Anne is also active in commercial litigation and has developed particular expertise in the field of medical cannabis, an area in which she has been closely involved since the early stages of its pilot program in France.

Anne joins an established and highly regarded Eversheds Sutherland team in France, known for its strong international reach and recognized expertise in the Healthcare and Life Sciences sector. Her arrival will further enhance the firm’s regulatory offering, responding to growing client demand across key areas including advertising, transparency obligations, patient support programs and health data protection.

Admitted to the Paris Bar since 1998, Anne holds a PhD in European Law from Université Nancy II. She began her career in the Competition and European Law team at CMS Francis Lefebvre, where she developed extensive expertise in regulated sectors, from telecommunications to the pharmaceutical industry. She then joined Intuity, a firm specializing in pharmaceutical and regulatory law, where she practised for nearly ten years until 2017, when she joined the Paris office of Hoyng Rokh Monegier, where she led the Regulatory Pharma practice.

Anne Servoir’s arrival coincides with that of partner Tiana Rambatomanga and her team, who joins to lead a newly established fund structuring practice, further illustrating Eversheds Sutherland’s growth strategy and the expansion of its multidisciplinary offering in Paris.

Alexander Niethammer, European Managing Partner, Eversheds Sutherland, said:

“Tiana and Anne both strengthen areas where we’ve been actively investing across Europe. Tiana’s arrival adds real weight to our private capital offering, while Anne brings a depth of pharmaceutical regulatory experience that is hard to replicate.

“What matters to us is having the right people in the right places, with the credibility and gravitas to lead in their markets. We have an ambitious vision for our European business, and few firms are genuinely positioned to bring together this combination of sector expertise and cross-border capability. These appointments reflect that direction.”

Catherine Detalle, Senior Office Partner, Paris, Eversheds Sutherland, said:

“I am pleased to welcome Anne to the Paris office. Her arrival is fully aligned with our growth strategy in France, which focuses on building strong sector expertise in direct response to our clients’ expectations.”

Gaëtan Cordier, Head of Commercial Advisory France, Eversheds Sutherland, said:

“Anne’s appointment forms part of the firm’s global strategy to provide clients, in France and internationally, with a unique combination of expertise in pharmaceutical and regulatory matters.”

Anne Servoir, Partner, Eversheds Sutherland, said:

“I am delighted to join Eversheds Sutherland, whose commitment to teamwork and international culture I share, and to contribute to the firm’s development in close collaboration with teams across its global network.”

As part of its continued focus on strengthening key markets, Eversheds Sutherland has made a number of recent hires including Partner Alexander Wojtek in Hamburg, and Partners Simon Thomas and Nichola Donovan who have joined the global law firm’s London-based capability.